Publications by authors named "Rachel Middleton"

Claim this Profile
P
Post-Transplant Cardiovascular Disease in Kidney Transplant Recipients: Incidence, Risk Factors, and Outcomes in the Era of Modern Immunosuppression.
Chukwuma Austin Chukwu, Anirudh Rao, Rachel Middleton, Philip A Kalra

J Clin Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Birth and Beyond (BABY) study: protocol for a birth cohort study investigating the social and environmental determinants of pregnancy-related outcomes in Black American families.
Betty Lin, Rachel R Middleton, Bethlehem Terefe, Allison A Appleton, Beth J Feingold

BMJ Open· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of primary renal disease upon outcomes after renal transplant.
Shona Garland, Kairi Pullerits, Chukwuma A Chukwu, Rajkumar Chinnadurai, Rachel Middleton

Clin Transplant· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, Risk Factors, and Outcomes of De Novo Malignancy following Kidney Transplantation.
Chukwuma A Chukwu, Henry H L Wu, Kairi Pullerits, Shona Garland, Rachel Middleton

J Clin Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and histopathologic predictors of recurrent glomerulonephritis after kidney transplantation.
Chukwuma A Chukwu, Christopher Holmberg, Joshua Storrar, Rachel Middleton, Smeeta Sinha

Clin Transplant· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort.
Kairi Pullerits, Shona Garland, Sharmilee Rengarajan, Malcolm Guiver, Rajkumar Chinnadurai, Rachel J Middleton

Viruses· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing recurrent urinary tract infections in kidney transplant recipients using smartphone assisted urinalysis test.
Chukwuma A Chukwu, Anirudh Rao, Phillip A Kalra, Rachel Middleton

J Ren Care· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resilience predicts positive mental health outcomes during the COVID-19 pandemic in New Yorkers with and without obsessive-compulsive disorder.
Dianne M Hezel, Amy M Rapp, Michael G Wheaton, Reilly R Kayser, Sarah V Rose, Rachel Middleton

J Psychiatr Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing Uptake of COVID-19 Vaccination and Reducing Health Inequalities in Patients on Renal Replacement Therapy-Experience from a Single Tertiary Centre.
Dimitrios Poulikakos, Rajkumar Chinnadurai, Saira Anwar, Amnah Ahmed, Chukwuma Chukwu, Rachel Middleton

Vaccines (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alemtuzumab in renal transplantation. Reviews of literature and usage in the United Kingdom.
Chukwuma A Chukwu, Harry V M Spiers, Rachel Middleton, Phillip A Kalra, Argiris Asderakis

Transplant Rev (Orlando)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation: A Randomized Clinical Trial.
Edna B Foa, Helen Blair Simpson, Thea Gallagher, Michael G Wheaton, Marina Gershkovich, Rachel Middleton

JAMA Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre.
Chukwuma A Chukwu, Kassir Mahmood, Safa Elmakki, Julie Gorton, Phillip A Kalra, Rachel Middleton

PLoS One· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Shielding and First Dose of COVID-19 Vaccination in Kidney Transplant Recipients.
Rachel J Middleton, Julie Gorton, Edmond O'Riordan, Sean Knight, Philip A Kalra

Nephron· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal change in c-terminal fibroblast growth factor 23 and outcomes in patients with advanced chronic kidney disease.
Helen V Alderson, Rajkumar Chinnadurai, Sara T Ibrahim, Ozgur Asar, James P Ritchie, Rachel Middleton

BMC Nephrol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Exposure and Response Prevention With a Mobile App to Treat Obsessive-Compulsive Disorder: Feasibility, Acceptability, and Preliminary Effects.
Marina Gershkovich, Rachel Middleton, Dianne M Hezel, Stephanie Grimaldi, Megan Renna

Behav Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safely reducing haemodialysis frequency during the COVID-19 pandemic.
Michelle Da Silva Lodge, Thilini Abeygunaratne, Helen Alderson, Ibrahim Ali, Nina Brown, Rachel Middleton

BMC Nephrol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder.
David Pagliaccio, Rachel Middleton, Dianne Hezel, Shari Steinman, Ivar Snorrason

Proc Natl Acad Sci U S A· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing Exposure and Response Prevention to Address Poor Insight in Obsessive-Compulsive Disorder.
Rachel R Middleton, Dianne M Hezel

J Cogn Psychother· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in dialysis versus conservative care for older patients: A prospective cohort analysis of stage 5 Chronic Kidney Disease.
Maharajan Raman, Rachel J Middleton, Philip A Kalra, Darren Green

PLoS One· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the impact of older age on outcome in chronic kidney disease of different etiologies: a prospective cohort study.
Maharajan Raman, Darren Green, Rachel J Middleton, Philip A Kalra

J Nephrol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a Quality Improvement Program to Improve Guideline Adherence and Attainment of Clinical Standards in Dialysis Care: Report of Outcomes in Year 1.
Sajeda Youssouf, Azri Nache, Chandrakumaran Wijesekara, Rachel J Middleton, David Lewis

Nephron· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating renal function in old people: an in-depth review.
Maharajan Raman, Rachel J Middleton, Philip A Kalra, Darren Green

Int Urol Nephrol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
Helen V Alderson, James P Ritchie, Sabrina Pagano, Rachel J Middleton, Menno Pruijm

Clin J Am Soc Nephrol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OLDER PEOPLE WITH CHRONIC KIDNEY DISEASE: DEFINITION, AND INFLUENCE OF BIOMARKERS AND MEDICATIONS UPON CARDIOVASCULAR AND RENAL OUTCOMES.
Maharajan Raman, Darren Green, Rachel J Middleton, Philip A Kalra

J Ren Care· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
Helen V Alderson, James P Ritchie, Rachel Middleton, Anders Larsson, Tobias E Larsson

Nephrology (Carlton)· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis